The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 25, 2018

Filed:

Dec. 01, 2017
Applicant:

Selux Diagnostics, Inc., Watertown, MA (US);

Inventors:

Aleksandar Vacic, Watertown, MA (US);

Nathan Purmort, Watertown, MA (US);

Eric Stern, Watertown, MA (US);

Anna Passernig, Los Gatos, CA (US);

Paul Otten, Los Gatos, CA (US);

Randy Tragni, Los Gatos, CA (US);

Ronan Hayes, Los Gatos, CA (US);

Andriy Tsupryk, Los Gatos, CA (US);

Bruce Richardson, Los Gatos, CA (US);

Assignee:

SELUX DIAGNOSTICS, INC., Charlestown, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12M 1/34 (2006.01); G01N 35/02 (2006.01); B01J 20/04 (2006.01); C12Q 1/18 (2006.01); G01N 21/01 (2006.01); G01N 35/00 (2006.01); G01N 35/10 (2006.01); C12M 1/00 (2006.01); C12M 1/26 (2006.01); C12M 1/36 (2006.01); G01N 35/04 (2006.01);
U.S. Cl.
CPC ...
G01N 35/02 (2013.01); B01J 20/041 (2013.01); C12Q 1/18 (2013.01); G01N 21/01 (2013.01); G01N 35/00 (2013.01); G01N 35/0099 (2013.01); G01N 35/028 (2013.01); G01N 35/1065 (2013.01); C12M 33/10 (2013.01); C12M 41/36 (2013.01); C12M 41/48 (2013.01); C12M 47/02 (2013.01); G01N 2021/0112 (2013.01); G01N 2035/00118 (2013.01); G01N 2035/00237 (2013.01); G01N 2035/00346 (2013.01); G01N 2035/00356 (2013.01); G01N 2035/00465 (2013.01); G01N 2035/00485 (2013.01); G01N 2035/00524 (2013.01); G01N 2035/00841 (2013.01); G01N 2035/0425 (2013.01);
Abstract

In some aspects, automated rapid antimicrobial susceptibility testing systems for performing a multi-assay testing sequence can include an automated incubation assembly having a nest assembly adapted to house at least one test panel having a plurality of wells for receiving a sample comprising microorganisms originating from a clinical sample, the incubation assembly facilitating incubation of one or more test panels in order to undergo the multi-assay testing sequence; a robotic handling assembly configured to accept one or more incoming test panels and move them to and from the incubation assembly for incubation between each assay of the multi-assay testing sequence; an automated liquid handling assembly configured to exchange one or more fluids in the plurality of wells of the test panels; and an optical assembly for interrogation and readout of each assay of the multi-assay testing sequence being performed in the plurality of wells.


Find Patent Forward Citations

Loading…